Cure51
FranceEntry
2024
Hold
2yr
Status
Active
Who owns Cure51?
Cure51 is a French Healthcare / Digital Health company, currently owned by Sofinnova Partners since 2024 and Hitachi Ventures.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Hitachi VenturesHitachi Ventures Fund III · 2023 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2024 · present
Sofinnova PartnersActive
2024 · present(2yr) · Sofinnova Digital Medicine I · 2022 · VC
Hitachi VenturesActive
2024 · present(2yr) · Hitachi Ventures Fund III · 2023 · VC
More from Hitachi Ventures Fund III
Other portfolio companies in the same fund.
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Cure51?
Cure51 is currently owned by Sofinnova Partners and Hitachi Ventures, through Hitachi Ventures Fund III, since 2024.
When did Sofinnova Partners and 1 other acquire Cure51?
Sofinnova Partners and 1 other acquired Cure51 in 2024.
Who has owned Cure51 over time?
Cure51 has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Digital Medicine I · since 2024; Hitachi Ventures · via Hitachi Ventures Fund III · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue